MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with B

Betamethasone

Betamethasone 0.1% foam

No stability information

Stability notes for Betamethasone 0.1% foam

There are no stability notes for this medicine.

Suppliers (4) of Betamethasone 0.1% foam
Bettamousse 0.1% cutaneous foam (Lexon (UK) Ltd)
Bettamousse 0.1% cutaneous foam (Necessity Supplies Ltd)
Bettamousse 0.1% cutaneous foam (RPH Pharmaceuticals AB)
Bettamousse 0.1% cutaneous foam (Sigma Pharmaceuticals Plc)

Betamethasone 500microgram soluble tablets sugar free

Incompatible

Stability notes for Betamethasone 500microgram soluble tablets sugar free

Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA. Formulation not suitable for use in MCAs.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Betamethasone 500 microgram soluble tablets sugar free (RPH Pharmaceuticals AB).

Suppliers (8) of Betamethasone 500microgram soluble tablets sugar free
Betamethasone 500microgram soluble tablets sugar free (A A H Pharmaceuticals Ltd)
Betamethasone 500microgram soluble tablets sugar free (Alliance Healthcare (Distribution) Ltd)
Betamethasone 500microgram soluble tablets sugar free (Medihealth (Northern) Ltd)
Betamethasone 500microgram soluble tablets sugar free (Necessity Supplies Ltd)
Betamethasone 500microgram soluble tablets sugar free (Phoenix Healthcare Distribution Ltd)
Betamethasone 500microgram soluble tablets sugar free (Roma Pharmaceuticals Ltd)
Betamethasone 500microgram soluble tablets sugar free (RPH Pharmaceuticals AB)
Betamethasone 500microgram soluble tablets sugar free (Tillomed Laboratories Ltd)

Betamethasone dipropionate 0.05% scalp lotion

No stability information

Stability notes for Betamethasone dipropionate 0.05% scalp lotion

There are no stability notes for this medicine.

Supplier

Diprosone 0.05% lotion (Organon Pharma (UK) Ltd)

Betamethasone valerate 0.1% lotion

No stability information

Stability notes for Betamethasone valerate 0.1% lotion

There are no stability notes for this medicine.

Supplier

Betnovate 0.1% lotion (GlaxoSmithKline UK Ltd)

Betamethasone valerate 0.1% scalp application

No stability information

Stability notes for Betamethasone valerate 0.1% scalp application

There are no stability notes for this medicine.

Suppliers (4) of Betamethasone valerate 0.1% scalp application
Betacap 0.1% scalp application (Dermal Laboratories Ltd)
Betnovate 0.1% scalp application (GlaxoSmithKline UK Ltd)
Betnovate 0.1% scalp application (Lexon (UK) Ltd)
Betnovate 0.1% scalp application (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.